However, DDMSNP treatment to the cancer cells caused significant (P < 0.005) reduction in N-cadherin expression of MDAMB-231 cells and notable increase in E-cadherin expression of 4T1 cells (Fig. S4A–C). Here, CDH2 is linked to cancer.